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ABSTRACT A dynamical mathematical model of the acute myeloblastic leukemic
state is proposed in which normal neutrophils and their precursors, and leukemic
myeloblasts, proliferate as distinct but interacting cell populations. Each population
has a Go compartment, consisting of resting cells, that acts as a control center to
determine the rate of proliferation. These rates are assumed to depend on the total
number of cells in the combined populations. The presence of the leukemic popula-
tion destabilizes the homeostatic state of the normal population, which is stable in the
absence of leukemic cells, and drives the system to a new stable state consisting entirely
of leukemic cells and no normal cells. Calculations based on the theory suggest that it
is able to simulate the kinetic features of this disease state, at least in its typical
manifestations.
INTRODUCTION
In a recent paper (1) we described a simple mathematical model of neutrophil produc-
tion and control in normal man, designed to incorporate most of the known quantified
kinetic parameters of granulocytopoiesis, representing a variety of experiments. In this
note we shall describe the dynamic or non-steady-state properties of the neutrophil
production system in the abnormal state acute myeloblastic leukemia (AML) (a brief
preliminary account of this work was presented in ref. 2). We emphasize at the outset
that the leukemic state referred to throughout this work is a subset of the variety of
myeloid leukemias that are clinically encountered. For example, we make no claim
that our model is applicable to chronic myelogenous leukemia, or to unusual leukemic
states such as those characterized by marrow hypoplasia.
The quantitative information regarding some kinetic aspects of this disease is exten-
sive (3-5), and was significantly advanced by the pioneering radioactive labeling ex-
periments of Cronkite and collaborators (6). We assume the reader is familiar with this
work.
We adopt the point of view, advocated by Clarkson (7), that there exist side by side
in AML two cell populations: the normal neutrophil cell system, and a population of
leukemic blood cells (LBC). Each population is assumed to possess feedback control
elements that regulate and control the total number of cells in the population. How-
ever, the leukemic cells are assumed to possess an aberrant set of kinetic parameters,
different from those of the normal population. In other words, our fundamental point
of view is that the leukemic state is not "uncontrolled growth," but rather, controlled
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growth with an abnormal set ofcontrol elements. Such a viewpoint has already been put
forth by others (8).
Various studies indicate the importance of colony-stimulating factor and colony-
stimulating cells in regulating granulopoeisis, and illuminate the nature of the control
system governing proliferative granulocytes in patients with AML (9-16). We do not
consider such mechanisms explicitly, but only assume the existence of some control
system, which is governed by the total population of the neutrophil system consisting
of both proliferative and nonproliferative cells. This assumption is the most novel
and critical one that we make, and one for which we cannot provide any direct experi-
mental evidence, although there is some indication that leukemic cells do act to inhibit
the colony-forming capacity of normal proliferative cells (13, 14, 16). The principal
justification for our assumptions resides in the comparison we shall make subsequently
of the deductions from our model with some of the known kinetic characteristics of
AML.
MODEL OF THE NORMAL NEUTROPHIL POPULATION
We shall review briefly the properties of our model of the normal neutrophil produc-
tion system in man (1). The five compartments comprising the model, together with
their interconnections representing cell fluxes, are shown in Fig. 1. The proliferative
pool consists of two compartments, an active compartment A and a resting compart-
ment Go. Stem cell influx is assumed to be negligible, and the proliferative pool is self-
maintaining. Following division of a cell in compartment A, the two daughter cells
enter the Go phase, which acts as a control center, and from which cells leave at random
to enter either the active phase A or the maturation compartment M at fractional rates
a and f, respectively.
The maturation compartmentM is a "pipeline," in which all cells mature for a fixed
time T. and then enter the marrow reserve compartment R. The latter is, like Go, a
"random" compartment, in which control is exercised on the rate per unit time 'y at
which cells leave to enter the blood compartment B. The compartments M and R
together comprise the nonproliferating precursor cells of the system, normally found
in the marrow.
The blood compartment B represents mature neutrophils in the circulating blood as
well as the "marginal granulocyte compartment" composed of sequestered cells, possi-
a
A A THE NORMAL STATE
FiGuRE I Schematic representation of the normal neutrophil production system. The active
compartment A and the resting compartment Go comprise the self-maintaining marrow pro-
liferative pool. The compartments labeled M and R represent the maturation and reserve pools
ofthe marrow. The compartment B represents the blood and marginal granulocytes. The quan-
tities a, , y, and A represent release rates along the indicated pathways (from ref. 1).
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FIGURE 2 The normalized control functions a/ao, B/ao, a'/a6, and #'/a4, given by Eqs. 2 and
4, are shown as functions of the total normalized cell population [N(t) + N'(t)I/A, consisting of
both normal and leukemic cells. It was assumed that al /ao - 216 /ao - a, /a6 - 2 /a6 -
1, and Nf'/N= 3. In the absence of leukemic cells and in the steady state, N(t)/N = I and a/aO =
/aO 1.
FIGuRE 3 Schematic representation of the leukemic cell population in the acute myeloblastic
leukemic state. The compartments A' and G6 represent the actively proliferating and
nonproliferating leukemic cell pools, respectively. Maturation is absent, and cells leave
G6 at fractional rates per unit time a' and P' to enter the active compartment A' and blood com-
partment B', respectively. Cells leave the blood at random to die, at a fractional rate per unit
time A'.
bly on the walls of blood vessels. Compartment B is likewise a random compartment
from which cells disappear or die at random at a fractional rate per unit time A.
Control of proliferation is taken into account by making a and f8 depend on the
total population of the entire system at any time, N. This dependence is illustrated in
Fig. 2, which shows a and ,8 plotted as a function of the total (normalized) population.
In the absence of any leukemic cells, the abscissa represents the population number
N/N. N is a prescribed parameter representing the total number of cells in the system
in the steady state. In the steady state, a = ,B = ao, a constant, i.e., for every cell
sent out of the marrow proliferative pool to mature, a cell is sent to the active compart-
ment to divide and replenish the proliferative pool. The shape of the curves a and ft
lead to the number N being maintained in a stable manner (in the absence of leukemic
cells) in response to perturbations.
The release rate -y of cells from the marrow reserve compartment depends on the
number of cells in the blood compartment N., in a manner similar to the dependence
of a or ,B on N. The steady-state value y = y is achieved when N. equals its steady-
state value N,B-
The values of the parameters, chosen to represent most of the known quantitative
kinetic observations of the neutrophil system in steady-state behavior, are shown in
Table I. The deduced neutrophil production rate in the steady state is no = 5.0 x 109
cells/h. It should be borne in mind that in practice, GO cells are indistinguishable from
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TABLE I
STEADY-STATE PARAMETERS OF THE NEUTROPHIL PRODUCTION SYSTEM
IN A 70 KG MAN*
Characteristic times Population numbersCompartment inferred from observation deduced from model
h
GI T,-T12 N -6.0 x 10'0
S Ts15 Ns 7.5x10'0
G2+m T2 -3 N2 -l.5x1010
A TA -30 NA -1.51x 10"
Go 1/ao- 20 No - 1.01 x 1011
M TMM- 96 M-4.85 x 10"
R l/'Yo- 90 NR -4.54 x 101
B I/X 9.7 NS -0.49 x 101
Sum T§- 246 N 1.24 x 10'2
*Taken from ref. 1.
$Inferred from observation.
§Tis the total transit time.
GI cells. Therefore, there is an effective distribution of transit times in the proliferative
state, resulting from the fact that the transit time in the Go compartment varies from
cell to cell.
MODEL OF THE LEUKEMIC CELL POPULATION AND
STEADY-STATE PROPERTIES
Leukemic myeloblasts are unable, by and large, to differentiate into maturer forms of
neutrophil precursors. Consequently, we assume that the LBC behave like a pro-
liferative pool only. The LBC are self-maintaining, and consist of an active compart-
ment A' and a resting compartment G' (see Fig. 3). In the resting state, the LBC leave
at random to enter either the active compartment A', or the blood compartment B',
at fractional rates at and j3', respectively. Here the GC compartment should perhaps
be thought of as a nonproliferating compartment, from which cells are either com-
mitted to proliferate again (enter A') or to be released to the blood (enter B'). Cells
in the blood are largely nonproliferative (8, 11, 17-20), and we assume this property is
strictly true. (Proliferative blood cells can be thought of as belonging to A' or Go.)
They disappear from the blood at random, at a fractional rate per unit time A'. The
cells entering the blood are for the most part destined to die (3, 4, 21, 22). Leukemic
cells may die even as they proliferate (4, 6, 21), although it is not possible to evaluate
such loss quantitatively. It seems most plausible that the principal mechanism of cell
loss is the release of cells to the blood. Therefore, in the interest of simplicity, we as-
sume that cell loss during proliferation is negligible.
This model of the leukemic population was previously utilized (23) to represent the
extensive and detailed kinetic observations, obtained with the aid of autoradiography,
made by Clarkson et al. (21) of two adults with AML. In making this representation
the leukemic cells were assumed to be in a quasi-steady state during the course of the
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observations. The values of the steady-state parameters of the leukemic cell population
so obtained are shown in Table II.
Other observations that are accounted for by the model are as follows. The produc-
tion rate of LBC at the time of diagnosis - 0.5-3 x 109 cells/h (17) (_ NBA').
The mean generation time of LBC is very long, perhaps of the order of 200 h, and
measurably longer than that of neutrophil precursors (3, 4, 21, 22, 23, 25, 27, 28).
There is no second wave seen in the labeled mitoses curve (21). If S-phase cells are ini-
tially labeled, some labeled cells show up in the blood a few hours later (17).
In order to represent the dynamics of the leukemic blast cell population, we assume
that the control functions a' and W' depend on the total neutrophil precursor popula-
tion in such a way as to make the leukemic cell population tend to a stable population
number N', analogous to the behavior of the normal cell population by itself. How-
ever, the equilibrium number N' is assumed to be substantially greater than the
equilibrium number N that characterizes the normal cell population. The control
functions a andft are likewise assumed to depend on the total cell population, normal
and leukemic. Thus, speaking anthropomorphically, we can say that normal cells are
fooled by the leukemic cells, and recognize them as normal. The dependence of the
control functions a, tl, a', and f#' on the total normal plus leukemic cell population is
illustrated in Fig. 2.
The system of differential equations which comprise our model are similar to those
for the normal population (1), with the obvious extension of the number of compart-
ments. They can be found in the Appendix. By specifying the characteristic control
functions, the values of all the parameters of the model, and the initial state of the sys-
tem at t = 0, the behavior of the system for all future times is found by integrating the
equations. From such solutions the curves in Figs. 4-7 were obtained. It can be seen
that cell fluxes from one compartment to another are represented at any moment, and
evolve in time as the leukemic population increases. Such a dynamical model is to be
TABLE II
QUASI-STEADY-STATE PARAMETERS OF LEUKEMIC CELLS IN AML*
Mean cell Number ofcells at Other references thatCompartment Metnme time of. e .at support inferences oflifetime time of observation cl rni ie
cell transit times
h
GI Tlo 0 N;/(No+N) 0
St T;-20 N'/(No + N2) - 0.079 5,24
GI +m' T2 -5 NI/(NI + N,) -0.020 24,25,26
A' T -25 N,/(No +N ) -0.099
G6 1 /a' - 227t N6/(N6 + NA) - 0.901
B' I/X' -36 N§ -5.3 x 1010 3,17
*Taken from ref. 23 and inferred from the observations ofClarkson et al. (21).
tThis quantity represents the mean lifetime defined as mean age ofa cell in Go, or mean cell transit time. The
mean interdivision time defined as the time interval between cell birth and subsequent division, is l/2a6 +
TA - 139h.
§Mean number ofleukemic cells observed in the blood oftwo adults.
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contrasted with other simplistic representations of the growth of a single tumor popu-
lation (29), that assume that the tumor is in steady exponential growth. It will be
shown that the latter condition is satisfied only during the early unobserved growth
phase of the LBC.
DYNAMICAL PROPERTIES OF THE MODEL
The explicit functional representation of the control functions a' and ,B' are given in the
Appendix as Eqs. 2. The steady-state parameter N' which appears in the control func-
tions for the leukemic cells, is chosen to be 3 X 1012, or 2.4 times larger than N, the
corresponding parameter of the normal cells. This value of N' was chosen on the basis
that the observed mean number of LBC present in children (10-14 yr old) who died
with acute lymphocytic leukemia was 1.65 x 10'" cells (30). By extrapolation of
weight, the mean number of cells at death in a 70 kg man with leukemia is inferred to
be 2.9 x 1012. Such an estimate is in agreement with other estimates of the number of
LBC in adults in advanced stages of leukemia (4).
With this value of N', the qualitative effect on the normal population of the presence
of the leukemic cell population can already be inferred from Fig. 2. Thus, suppose the
normal population number is at its steady-state level N, and a small number of leu-
kemic cells are introduced, say 10, so that the total population is greater than N. Then,
so far as the normal cell control functions a and # are concerned, the total population
is greater than its homeostatic level N, jt is greater than a, and the normal population
production begins to turn off and operate below a self-sustaining level. The leukemic
cells, on the other hand, recognize the total as being less than its steady-state level N',
so that a' is greater than fl', and the leukemic population continues to increase. This
results in a further decline in production of normal cells, with consequences that are
ultimately devastating for the normal cell population.
What happens is seen graphically in Fig. 4, which shows the behavior of the normal
blood neutrophil population number NB, and the leukemic blood cell population
number NB, as functions of the time t. Also shown is the total blood population
number NB + NB. Similar curves are obtained for the total populations of the nor-
mal and leukemic cells. The curves of the total leukemic population for three different
sets of values of a' and : (the rightmost curve corresponding to the case illustrated
in Fig. 4) are shown in Fig. 5. The curves of Figs. 4 and 5 have the following qualita-
tive features in common.
After a very short transient period, the LBC increase at a constant fractional rate,
that is to say, they are in steady exponential growth for a long time, until a stationary
growth phase appears, as N' approaches its steady-state level N'. In the first phase
no clinical manifestations appear since the leukemic cell population is negligible in
comparison with the normal population, which remains at its steady-state level N. It
follows from Eqs. 2 that during this time, a' and fl' are constant. It is shown in the
Appendix that, under such conditions, the leukemic cell population grows at a con-
stant rate, the excess of the birth rate over the death rate, proportional to a' - f8' (see
Eq. 11).
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FIGuR 4 The behavior of the normal blood neutrophil population N5, the leukemic blood cell
population number N', and the sum N5 + N', as functions of the time. At t - 0, 10 leukemic
cells are assumed to be introduced into the marrow, in S-phase, while the normal neutrophil
cells and their precursors are in a steady state. The steady state parameters of the system are as
given in Tables I and II. The functions a, f, a', and ,' are given by Eqs. 2 and 3 with
ao -. aI - 2 #1 - 0.05/h, v - 4, acj - 0.0044/h,a - 0.0022/h, 0.001I/h, N - 1.24 x 1012,
and N' -3 x 1012.
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FIGuRn 5 The curve on the right represents total leukemic blood cell population as a function
of time for tne same case as illustrated in Fig. 4. For the curve on the left, it was assumed that
a' - 0.0088/h, and , 0.0044/h, while for the middle curve, a; - 0.0044/h, and ,B; - 0.0022/h.
Other parameter values were chosen as for Fig. 4.
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However, when N' becomes comparable to N, the presence of the leukemic popula-
tion in large numbers appears to the normal homeostatic mechanism of control of
proliferation as an overpopulation of normal cells. Hence, the production rate is re-
duced below the self-maintenance level, and the normal population suffers a decline,
as is seen for the normal blood neutrophils in Fig. 4. It is in this stage that diagnosis
of the disease is usually made. The number of leukemic cells usually seen at first diag-
nosis varies from 1011 cells upwards (30). After this, the growth of the total leukemic
population behaves in a Gompertzian manner, as observed in the growth of animal
tumors (31-35), and the total LBC number slowly approaches its asymptotic limit N'.
(In fact, it can be shown mathematically that the differential equations for the popula-
tions in the Go and A' compartments are asymptotically Gompertzian in nature for
large times.) Concurrently, the normal population rapidly disappears.
For the three growth curves shown in Fig. 5, the values of a' - were chosen to
be (reading from left to right), respectively, 0.0044/h, 0.0022/h, and 0.0011/h. These
values correspond to mean doubling times (see Eqs. 11 and 12) of 12, 21, and 39
days, and mean lifetimes of 1.3, 2.3, and 4.3 yr, respectively. For Figs. 4 and 5, a and
,B were prescribed by Eqs. 3, but the curves are unaltered if Eqs. 4 are utilized instead.
Unfortunately, almost no quantitative information exists that could fix the values of
these parameters.
The possibility that the natural lifespan of leukemia, measured from the first
(unobserved) appearance in the body of some leukemic cells, may be 5 yr or longer
receives support from observations of the incidence of leukemia among survivors of
the Hiroshima atomic bomb. It was found that the incidence of leukemia did not in-
crease above its normal expected level until about 18 mo after exposure to the bomb,
and that the increased incidence did not reach its peak until about 5-7 yr later (36).
Fig. 6 shows the behavior of the labeling index of the leukemic cells for each of the
three cases cited, which is the ratio of leukemic cells in S-phase to the total leukemic
marrow (Go + A') population. During the stage of the disease when the leukemic
cell population is small compared with normal cell population and in steady ex-
ponential growth, both the number of leukemic cells in S-phase and the total leukemic
marrow population maintain a fixed ratio, so that the labeling index remains constant,
although at a level below that of the normal proliferating marrow cells. Ultimately,
when the growth rate of the leukemic population declines and the population begins
to approach its stationary phase, cells accumulate in Go relative to S', and the
labeling index declines asymptotically to its new stationary level.
Although the labeling index in patients with AML is quite variable, in general its
value is very low and below the value seen for normal myeloblasts (18, 19, 21, 37, 38).
The mitotic activity is also low. Furthermore, the labeling index and mitotic index of
LBC do decline as the disease progresses (3, 4, 22). In terms of the model, these obser-
vations suggest that the patients are being observed at different times during the de-
clining phase of one of the labeling index curves shown in Fig. 6. Alternatively, the
varying values of the labeling index could also reflect in part different intrinsic growth
rates of the LBC (as represented by the different horizontal phases of the curves in
Fig. 6).
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FIGURE 6 The labeling index of leukemic cells as a function of time for each of the three cases
(reading from left to right) illustrated in Fig. 5.
FIGuRE 7 The marrow cellularity asa function of time for each of the three cases (reading
from left to right) illustrated in Fig. 5. The marrow cellularity is defined as the ratio of the
total marrow population (normal plus leukemic cells) to the normal steady-state marrow popula-
tion N - NB.
In Fig. 7 is shown the marrow cellularity corresponding to the three cases displayed
in Fig. 5. Here marrow cellularity is defined as the ratio of the total marrow popula-
tion to the normal steady-state marrow population, which equals N - NB. During the
early stages of the disease, this ratio is seen to be unity, as we expect. With the initia-
tion of the decline in the normal population, the marrow cellularity ratio momentarily
declines. This decline occurs because the disappearance of the normal marrow popu-
ulation is temporarily greater than the increase in marrow population due to the
leukemic cells. Subsequently, the marrow is overwhelmed by the continued increase
in the leukemic cell population, especially those in G', and the cellularity rises sharply.
In the advanced phase of the disease, the marrow cellularity ratio approaches a con-
stant asymptotic value that depends on N', increasing or decreasing in direct propor-
tion to it. Thus by appropriately increasing N', it is possible to produce marrow cel-
lularities as much as 5 or 10 times normal, as seen in patients with AML in the
advanced stage of the disease (B. D. Clarkson, personal communication).
DISCUSSION AND CONCLUSIONS
A mathematical model of the total neutrophil production has been introduced that
is designed to represent the kinetic behavior of neutrophil cells and their precursors
in the disease state, acute myeloblastic leukemia. The model makes a number of as-
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sumptions regarding the mode of action of cells, the most critical of which are the
following.
(i) There are two distinct populations, a normal cell population and a leukemic cell
population, which function under a qualitatively similar but quantitatively different
set of controls.
(ii) Each population has its own Go or resting compartment, which is a proliferative
control center. In it, the decision is made as to whether a cell will enter an active pro-
liferative compartment and subsequently divide, or whether the cell will not prolifer-
ate. In the latter case, a normal cell undergoes a period of maturation, enters the
blood, and ultimately dies. If the cell is a leukemic cell, it enters the blood directly and
ultimately dies.
(iii) The decision as to whether a cell proliferates or not (whatever the biochemical
mechanism controlling this decision is eventually shown to be) depends on the total
number of cells in the population.
(iv) Normal neutrophil precursors in Go do not distinguish leukemic cells, and re-
gard them as part of the total population.
With the aid of these assumptions, the model appears able to successfully simulate
some of the typical dynamical features of the acute myeloblastic leukemic state. The
main effect of the interaction of the leukemic cell population, which possesses an
aberrant set of kinetic parameters, with the normal population, is to destabilize the
normal homeostatic control mechanisms of the latter population. The new stable state
of the system, to which the population is (unfortunately) driven, is one in which there
are no normal neutrophil cells or precursors, and all leukemic cells.
Because the model parameters are adjustable, different choices of values of these
parameters permit a spectrum of realizations of the model. Thus, the variety of re-
sponses seen in humans can be accounted for by assigning different parameter values
to different individuals. For example, longer or shorter natural histories are obtained
as a result of slight changes in value of some of the dynamical parameters. It is pos-
sible that the "smoldering" form of leukemia, in which there may be no apparent
progression of the disease for long periods of time, is characterized by a very long na-
tural history. Alternatively, it is conceivable that the parameter N' has a value that is
initially about the same as M, so that the normal neutrophil population tolerates the
presence of the leukemia cells, which maintain themselves in a quasi-steady state near
the level N. The sudden transition, after a period of years, say, to the acute phase of
the disease perhaps represents a sudden increase, for unknown reasons, in IVR to a value
greater than N.
The utility of a concrete mathematical model is that specific predictions about the
natural history of the disease are made that may be susceptible to observational test,
as for example, the assumptions listed above. Because of the successful qualitative
simulation of the kinetic behavior of the disease, the concept of two distinct cell popu-
lations, normal and leukemic, is supported. At the present time, observations of ki-
netic features of leukemic cells in patients with AML must perforce be carried out
when there are at least about 1010 or 10" leukemic cells present, as otherwise, they are
too few in number to be detected. The presence of this many leukemic cells implies
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that a late stage of the disease is being observed, when the leukemic cells are already
in the quasi-steady state phase of their Gompertzian growth. Hence, it should not
surprise us that quantified knowledge of the dynamical properties of the system such
as death rates, growth rates, and their temporal dependence still eludes investigators.
Observations of the system when it is subjected to the large perturbations produced
by chemotherapeutic drug doses can perhaps be helpful in this connection.
Furthermore, a mathematical model such as the one we have proposed can be ap-
plied to the simulation of the possible outcomes of various chemotherapeutic treat-
ment regimens. Such simulation can be used for optimizing the treatment scheduling
in the sense of maximizing the cytocidal action of the drug on the leukemic population
while minimizing the toxicity, or cytocidal action of the drug on the normal popula-
tion. This application of the model is the subject of a subsequent investigation.
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APPENDIX
Mathematical Details ofthe Model
The mathematical formalism follows that of ref. 1, where a fuller discussion of relevant equa-
tions and their derivation can be found. Thus, cell density functions of the A', Go, and B'
compartments are introduced, which when integrated over age or maturity variables, yield
ordinary differential-difference equations for the total number of cells in each compartment,
as follows.
dN'(t)/dt = a'(t)No(t) l'(t TA )N'(t - T) t < TA
dN'(t)/dt = - [a'(t) + /3'(t)]No(t) + 2 l'(t_TA <jN (t - TA), t < TA,
dN' (t)ldt = ,'(t)N0'(t) - X'N'(t), O < t.(1
Here, NA , No, and NB represent the number of leukemic cells in the A', Go, and B' compart-
ments, respectively, at time t, and f'(a) represents the initial distribution of leukemic cells in
compartment A' as a function of age a. The control functions a' and fl' are defined as fol-
lows,
a' =a + a'log N
N(t) + N'(t)
N(t) + N'(t) (2)
where N(t) is the total normal population of neutrophils and their precursors at time t, and
N'(t) is the total number of LBC, equal to NA (t) + No(t) + ND(t).
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The equations satisfied by the total populations of the normal compartments, which are
similar to the above, are given in ref. 1. However, the functions a and , there are now de-
fined in terms of both N(t) and N'(t) to be
a(t) = aO + ai([ +NA )1 )
A(t) = ao + X'([N(t) + N'(t)] -
where v is a positive number, or alternatively,
a(t) = aO + a, log [NI +N'(t]
0(t) = ao + # log [N(t) + N(t)]
(3)
(4)
Stability of the total population at the homeostatic level iVrequires that al > f,,.
To represent those cells in the active compartment that are exclusively in S-phase, the active
compartment is partitioned into three subcompartments consisting of the GI cells, the S-phase
cells, and the G2 + m cells. Then the first Eq. 1 is replaced by the three equations
dN'(t)/dt = a'(t)NI(t)-J-(t),
dN'(t)/dt = J;(t) - J'(1)
dN'(t)/dt = JI(t) - J2(t), (5)
where
fl (T -
G'(Tr- t)
J,(t) =tf,'(T; + TI - t)
La'(t - T- Tv)N1(t - T- TJ),
+2T2-tt,
J( '(TA + T)- t),
c,(t- TA )NO(t TA
O < t < T;
t > T;
O < t < T'
Ts < t < T + Ts
t > T; + T'
O < t < T2
T2 < t < T2 + T5
T2 + TS' < t < TA
t > TA.
Heref,'(a),fj'(a), andf2'(a) represent the three segments off'(a) in the three phases comprising
A'. Eqs. 5 replace the first Eq. 1 in this expanded formulation, and are needed to obtain the
labeling curves of Fig. 6. In addition, the second Eq. 1 is replaced by
dNo/dt = 2J(t) - [a'(t) + ,B'(t)]No(t) (7)
For a given choice of values of the parameters of the system and of initial conditions, Eqs. 1
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and the corresponding equations for the normal compartments (Eqs. 28 and 29 of ref. 1), sup-
plemented by Eqs. 3 and 4, were solved numerically with the aid of the CDC 6600 computer of
the Courant Institute of Mathematical Sciences of New York University. Figs. 4-7 represent
computer curves generated in this manner.
When N'(t) is small compared with N, and the normal population is at its normal homeo-
static level N(t) = N, then a' and ,' are essentially constant and given by Eqs. 2 as
a't = a-' = aO+ a log (N'/N),
I
=
at
= aO+( log (N'/N) . (8)
Then it is possible to show that the leukemic compartment populations can exist in a state of
steady exponential growth with growth rate
-y, that is,
N'(t) = c , (9)
where c and y are constants. y is given as the solution to the transcendental equation
a' +,B' +y = 2a'e-tYs (10)
with a' and B' defined in Eq. 8. If yT' << 1, then Eq. 10 can be simplified and solved ex-
plicitly for y, that is,
'y = 19-')/(I + 2iv'TA)*(1
The doubling time is expressed in terms of -y as -y ' log 2. The natural lifetime of the acute
myeloblastic state can be estimated as, essentially, the time T it takes one cell to grow into
1012 cells. Thus, from Eq. 9, with c = 1 and N'(T) = 1012,
T = Y 1 12 logl1 = 27.6 Y'. (12)
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